I Tried Keeping Up With BMY, Dead
OMG, BMY is like that friend who’s always “working on themselves” but never really shows up to the party. They’re all about this fancy cancer stuff—follicular lymphoma? Sounds like a bad hair day, not a market trend. Anyway, they’re bragging about these new therapies like monoclonal whatever and CAR T-cell things. I don’t even know if that’s a robot or a new TikTok dance move.
Like, cool, less toxic chemo sounds great, but girl, this stuff sounds complicated AF. I’m just waiting for BMY to drop a hit drug instead of a confusing science project no one remembers. It’s like they want to be the healthcare drama queen but no one’s really glued to the tea yet.
If you wanna see some real tower drama, check out this post. At least that’s a skyscraper flex, not cancer buzzwords.
Honestly, BMY’s market moves are softer than my excuses for missing brunch. You can bet I’m watching, but honey, wake me up when it’s actually popping.
Want chaos in your portfolio? Take my quiz → /trading-quiz